Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation.

[1]  E. Romagnoli,et al.  Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. , 1994, European journal of endocrinology.

[2]  B. Grabensee,et al.  Monitoring of osteoblast activity with an immunoradiometric assay for determination of bone alkaline phosphatase mass concentration in patients receiving renal transplants. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[3]  J. Kanis,et al.  Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  P. Delmas,et al.  Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. , 1993, The Journal of clinical endocrinology and metabolism.

[5]  L. Mosekilde,et al.  Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  M. Fallon,et al.  EVIDENCE THAT CYCLOSPORINE G IS LESS DELETERIOUS TO RAT BONE IN VIVO THAN CYCLOSPORINE A , 1992, Transplantation.

[7]  J. Griño,et al.  Serum calcitriol concentrations in the early follow-up after renal transplantation. , 1992, Transplantation proceedings.

[8]  B. Julian,et al.  Musculoskeletal complications after renal transplantation: pathogenesis and treatment. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  E. Bonucci,et al.  Procollagen type I C-terminal extension peptide in predialysis chronic renal failure. , 1992, American journal of nephrology.

[10]  M. Prummel,et al.  Bone-alkaline phosphatase as indicator of bone formation. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[11]  J. Risteli,et al.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. , 1990, Clinical chemistry.

[12]  D. Rowe,et al.  1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. , 1989, Endocrinology.

[13]  S. Surachno,et al.  Bone repair in cyclosporin treated renal transplant patients. , 1989, Transplantation proceedings.

[14]  S. Krane,et al.  Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone fragment (1–34) , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  J. Kanis,et al.  Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[16]  R. Loertscher,et al.  Persistent elevation of alkaline phosphatase in cyclosporine-treated renal transplant recipients. , 1983, Transplantation.

[17]  E. Schmidt,et al.  γ-Glutamyl-Transpeptidase , 1973 .

[18]  H. Bergmeyer.  Methoden der enzymatischen Analyse , 1962 .